UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

Virology (New York, N.Y.), 2024-10, Vol.598, p.110194, Article 110194

2024

Volltextzugriff (PDF)

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Journal of virology, 2014-04, Vol.88 (8), p.4237-4250

2014

Volltextzugriff (PDF)

Respiratory syncytial virus infection and novel interventions

Nature reviews. Microbiology, 2023-11, Vol.21 (11), p.734-749

2023

Volltextzugriff (PDF)

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PloS one, 2014, Vol.9 (6), p.e100392

2014

Volltextzugriff (PDF)

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Volltextzugriff (PDF)

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Journal of general virology, 2014-06, Vol.95 (Pt 6), p.1244-1254

2014

Volltextzugriff (PDF)

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Cell host & microbe, 2022-01, Vol.30 (1), p.41-52.e5

2022

Volltextzugriff (PDF)

Immunopathology of RSV: An Updated Review

Viruses, 2021-12, Vol.13 (12), p.2478

2021

Volltextzugriff (PDF)

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Virology (New York, N.Y.), 2016-07, Vol.494, p.215-224

2016

Volltextzugriff (PDF)

The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate

Journal of virology, 2023-01, Vol.97 (1), p.e0190022-e0190022

2023

Volltextzugriff (PDF)

Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F

Journal of virology, 2017-11, Vol.91 (22)

2017

Volltextzugriff (PDF)

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

Journal of virology, 2017-05, Vol.91 (10)

2017

Volltextzugriff (PDF)

Structure and function of respiratory syncytial virus surface glycoproteins

Current topics in microbiology and immunology, 2013, Vol.372, p.83

2013

Volltextzugriff (PDF)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

PloS one, 2017-04, Vol.12 (4), p.e0175792-e0175792

2017

Volltextzugriff (PDF)

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Journal of virology, 2015-09, Vol.89 (17), p.8974-8981

2015

Volltextzugriff (PDF)

Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

Journal of virology, 2022-04, Vol.96 (7), p.e0220121

2022

Volltextzugriff (PDF)

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Virology (New York, N.Y.), 2019-08, Vol.534, p.1-13

2019

Volltextzugriff (PDF)

Clinical and epidemiologic features of respiratory syncytial virus

Current topics in microbiology and immunology, 2013, Vol.372, p.39

2013

Volltextzugriff (PDF)

Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus

Viruses, 2024-05, Vol.16 (6), p.843

2024

Volltextzugriff (PDF)

Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine

PloS one, 2018-06, Vol.13 (6), p.e0199452-e0199452

2018

Volltextzugriff (PDF)

A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge

Journal of virology, 2017-06, Vol.91 (11)

2017

Volltextzugriff (PDF)

Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology

Journal of Virology, 2010-01, Vol.84 (2), p.1110-1123

2010

Volltextzugriff (PDF)

Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

Journal of Virology, 2011-01, Vol.85 (1), p.366-377

2011

Volltextzugriff (PDF)

Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats

Journal of virology, 2021-02, Vol.95 (6)

2021

Volltextzugriff (PDF)

1 – 25 von 1.621

Suche als RSS-Feed

Aktive Filter

ThemaVirology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.585)
Mit Volltextzugriff
(1.458)

Publikationsform

Sprache

Englisch
(1.618)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.529)
Life Sciences & Biomedicine
(1.476)
Respiratory Syncytial Virus
(1.129)
Humans
(1.080)
Animals
(896)
Biological And Medical Sciences
(783)
Microbiology
(770)
Fundamental And Applied Biological Sciences. Psychology
(705)
Respiratory Syncytial Viruses - Immunology
(643)
Respiratory Syncytial Virus Infections - Immunology
(533)
Mice
(507)
Female
(491)
Immunology
(486)
Mice, Inbred Balb C
(374)
Infectious Diseases
(370)
Viruses
(338)
Respiratory Syncytial Virus, Human - Immunology
(329)
Respiratory Syncytial Virus Infections - Virology
(325)
Infant
(319)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Respiratory syncytial virus infection and novel interventions

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

The race to make vaccines for a dangerous respiratory virus

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Immunopathology of RSV: An Updated Review

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate

Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

Structure and function of respiratory syncytial virus surface glycoproteins

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Clinical and epidemiologic features of respiratory syncytial virus

Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus

Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector

A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge

Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology

Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins

Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats

Aktive Filter

Suchergebnisse filtern